Advanced glycation end products increase permeability of brain microvascular endothelial cells through reactive oxygen species-induced vascular endothelial growth factor expression

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 4, 2012, Pages 293-298

  Niiya, Yoshimasa ^a   Abumiya, Takeo ^a   Yamagishi, Sho Ichi ^b   Takino, Jun Ichi ^c   Takeuchi, Masayoshi ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

Author keywords

Brain microvascular endothelial cells; diabetes mellitus; edaravone; permeability; reactive oxygen species; vascular endothelial growth factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MESSENGER RNA; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL CELL; AORTA; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; CELL LEVEL; CONTROLLED STUDY; COW; DIABETIC ANGIOPATHY; DRUG EFFECT; ENDOTHELIUM CELL; MICROVASCULATURE; MONOLAYER CULTURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN; CATTLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CEREBROVASCULAR DISORDERS; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; MICROCIRCULATION; OXIDATIVE STRESS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860124109     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.09.002     Document Type: Article

References (38)

1. T.S. Kern, and R.L. Engerman Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia Arch Ophthalmol 114 1996 306 310 (Pubitemid 26086737)
2. J.M. Starr, J. Wardlaw, and K. Ferguson Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging J Neurol Neurosurg Psychiatry 74 2003 70 76 (Pubitemid 36069039)
3. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592 (Pubitemid 39078671)
4. S. Yamagishi, K. Nakamura, and T. Matsui Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy Curr Drug Discov Technol 3 2006 83 88
5. M.C. Thomas, J.M. Forbes, and M.E. Cooper Advanced glycation end products and diabetic nephropathy Am J Ther 12 2005 562 572 (Pubitemid 41689757)
6. R. Wada, and S. Yagihashi Role of advanced glycation end products and their receptors in development of diabetic neuropathy Ann N Y Acad Sci 1043 2005 598 604 (Pubitemid 41123949)
7. M. Takeuchi, S. Kikuchi, and N. Sasaki Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease Curr Alzheimer Res 1 2004 39 46
8. A.M. Schmidt, S.D. Yan, and J.L. Wautier Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 84 1999 489 497 (Pubitemid 29138585)
9. A. Goldin, J.A. Beckman, and A.M. Schmidt Advanced glycation end products: Sparking the development of diabetic vascular injury Circulation 114 2006 597 605 (Pubitemid 44199649)
10. S. Yamagishi, S. Amano, and Y. Inagaki Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes Biochem Biophys Res Commun 290 2002 973 978 (Pubitemid 34687457)
11. S. Yamagishi, Y. Inagaki, and T. Okamoto Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J Biol Chem 277 2002 20309 20315 (Pubitemid 34967325)
12. P. Quehenberger, A. Bierhaus, and P. Fasching Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells Diabetes 49 2000 1561 1570
13. T. Kunt, T. Forst, and O. Harzer The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules Exp Clin Endocrinol Diabetes 106 1998 183 188 (Pubitemid 28356609)
14. G. Basta, G. Lazzerini, and M. Massaro Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses Circulation 105 2002 816 822 (Pubitemid 34174921)
15. G. Rashid, S. Benchetrit, and D. Fishman Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells Kidney Int 66 2004 1099 1106 (Pubitemid 39121015)
16. A. Bierhaus, T. Illmer, and M. Kasper Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE Circulation 96 1997 2262 2271 (Pubitemid 27425832)
17. S. Yamagishi, H. Fujimori, and H. Yonekura Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells Diabetologia 41 1998 1435 1441 (Pubitemid 28551614)
18. Y. Niiya, T. Abumiya, and H. Shichinohe Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species Brain Res 1108 2006 179 187 (Pubitemid 44278013)
19. T. Sato, M. Iwaki, and N. Shimogaito TAGE (toxic AGEs) theory in diabetic complications Curr Mol Med 6 2006 351 358
20. M. Takeuchi, R. Bucala, and T. Suzuki Neurotoxicity of advanced glycation end-products for cultured cortical neurons J Neuropathol Exp Neurol 59 2000 1094 1105 (Pubitemid 32006312)
21. Z. Makita, H. Vlassara, and A. Cerami Immunochemical detection of advanced glycosylation end products in vivo J Biol Chem 267 1992 5133 5138
22. J.D. Huber, R.L. VanGilder, and K.A. Houser Streptozotocin-induced diabetes progressively increased blood-brain barrier permeability in specific brain regions in rats Am J Physiol Heart Circ Physiol 291 2006 H2660 H2668 (Pubitemid 44904065)
23. B.T. Hawkins, T.F. Lundeen, and K.M. Norwood Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: Contribution of hyperglycaemia and matrix metalloproteinases Diabetologia 50 2007 202 211 (Pubitemid 46035869)
24. J.L. Wautier, C. Zoukourian, and O. Chappey Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J Clin Invest 97 1996 238 243
25. C. Renard, O. Chappey, and M.P. Wautier Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats Mol Pharmacol 52 1997 54 62 (Pubitemid 27318618)
26. E. Bonnardel-Phu, J.L. Wautier, and A.M. Schmidt Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo Diabetes 48 1999 2052 2058 (Pubitemid 29458371)
27. S. Yamagishi, K. Nakamura, and T. Matsui Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression J Biol Chem 281 2006 20213 20220 (Pubitemid 44065796)
28. K. Otero, F. Martinez, and A. Beltran Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells Biochem J 359 2001 567 574 (Pubitemid 33063380)
29. X.H. Guo, Q.B. Huang, and B. Chen Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells APMIS 114 2006 874 883 (Pubitemid 44967323)
30. A.A. Miller, G.R. Drummond, and H.H. Schmidt NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries Circ Res 97 2005 1055 1062 (Pubitemid 41668919)
31. H. Jørgensen, H. Nakayama, and H.O. Raaschou Stroke in patients with diabetes. The Copenhagen Stroke Study Stroke 25 1994 1977 1984 (Pubitemid 24291283)
32. S.E. Megherbi, C. Milan, and D. Minier Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: Data from the European BIOMED Stroke Project Stroke 34 2003 688 694 (Pubitemid 36307394)
33. M. Muranyi, M. Fujioka, and Q. He Diabetes activates cell death pathway after transient focal cerebral ischemia Diabetes 52 2003 481 486 (Pubitemid 36173206)
34. Z.G. Li, M. Britton, and A.A. Sima Diabetes enhances apoptosis induced by cerebral ischemia Life Sci 76 2004 249 262 (Pubitemid 39452909)
35. C. Jongen, J. van der Grond, and L.J. Kappelle Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus Diabetologia 50 2007 1509 1516 (Pubitemid 46879017)
36. D. Last, D.C. Alsop, and A.M. Abduljalil Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity Diabetes Care 30 2007 1193 1199 (Pubitemid 46684647)
37. B. van Harten, J.M. Oosterman, and B.J. Potter van Loon Brain lesions on MRI in elderly patients with type 2 diabetes mellitus Eur Neurol 57 2007 70 74
38. C. Toth, A.M. Schmidt, and U.I. Tuor Diabetes, leukoencephalopathy and rage Neurobiol Dis 23 2006 445 461 (Pubitemid 44109669)